Updates from the Exchange

A woman’s menstrual cycle – though critical for conceiving life, can also be painful, messy, and downright uncomfortable. And, women who...

Amphora, an investigational Multipurpose Vaginal pH Regulator (MVP-RTM), shows promise for the United States Food and Drug Administration...

On December 11, 2019, Amneal Pharmaceuticals received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug...

Researchers from the Georgia Institute of Technology, University of Michigan and FHI 360, are attempting to expand the number of user...

Researchers may have found a novel delivery mechanism that will allow an extended release birth control pill to provide one month of...

In late September, the Federal Drug Administration (FDA) hosted its second annual Complex Generic Drug Product Development Workshop...

Medicines360 and Allergan announced the U.S. Food and Drug Administration (FDA) approved the extension of LILETTA® (levonorgestrel...

Imagine using one product or method to safeguard against an unwanted pregnancy or a sexually transmitted infection. Well, there’s a tech...

Novel research from David Pépin’s lab's research may serve women as both a contraceptive and a fertoprotective – protecting against the...

The Demographic and Health Surveys (DHS) Program has updated its questionnaires for DHS-8. Since 1984, the DHS Program has provided...

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has publicly released its updated five-year...

On July 11, 2019, the U.N. Human Rights Council (HRC) adopted a new resolution on “Access to medicines and vaccines in the context of the...